TTPH
T. Rowe Price Associates’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-11,430
| Closed | -$32K | – | 2581 |
|
|
2019
Q4 | $32K | Buy |
+11,430
| New | +$32K | ﹤0.01% | 2500 |
|
|
2019
Q3 | – | Sell |
-163,600
| Closed | -$79K | – | 2553 |
|
|
2019
Q2 | $79K | Sell |
163,600
-865
| -0.5% | -$415 | ﹤0.01% | 2487 |
|
|
2019
Q1 | $220K | Buy |
164,465
+200
| +0.1% | +$268 | ﹤0.01% | 2379 |
|
|
2018
Q4 | $186K | Buy |
164,265
+35,300
| +27% | +$40K | ﹤0.01% | 2412 |
|
|
2018
Q3 | $356K | Buy |
128,965
+62,666
| +95% | +$173K | ﹤0.01% | 2273 |
|
|
2018
Q2 | $237K | Buy |
66,299
+100
| +0.2% | +$357 | ﹤0.01% | 2397 |
|
|
2018
Q1 | $203K | Sell |
66,199
-17,701
| -21% | -$54.3K | ﹤0.01% | 2398 |
|
|
2017
Q4 | $529K | Buy |
83,900
+55,100
| +191% | +$347K | ﹤0.01% | 2055 |
|
|
2017
Q3 | $197K | Buy |
28,800
+12,000
| +71% | +$82.1K | ﹤0.01% | 2398 |
|
|
2017
Q2 | $120K | Hold |
16,800
| – | – | ﹤0.01% | 2458 |
|
|
2017
Q1 | $154K | Hold |
16,800
| – | – | ﹤0.01% | 2434 |
|
|
2016
Q4 | $68K | Sell |
16,800
-100
| -0.6% | -$405 | ﹤0.01% | 2502 |
|
|
2016
Q3 | $65K | Hold |
16,900
| – | – | ﹤0.01% | 2485 |
|
|
2016
Q2 | $73K | Buy |
16,900
+100
| +0.6% | +$432 | ﹤0.01% | 2461 |
|
|
2016
Q1 | $78K | Hold |
16,800
| – | – | ﹤0.01% | 2439 |
|
|
2015
Q4 | $169K | Buy |
+16,800
| New | +$169K | ﹤0.01% | 2338 |
|